Literature DB >> 26508724

Alemtuzumab as a novel treatment for refractory giant cell myocarditis after heart transplantation.

Jonathan D W Evans1, Stephen J Pettit1, Martin Goddard2, Clive Lewis1, Jayan K Parameshwar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26508724     DOI： 10.1016/j.healun.2015.10.009

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  5 in total

1.  A case report of giant cell myocarditis after a syncope-related motor vehicle accident: an atypical presentation for a life-threatening condition.

Authors:  Lily A Pham; Joseph Chung; Callan Gavaghan
Journal:  Eur Heart J Case Rep       Date:  2022-07-11

2.  Alemtuzumab and Fatal Myocarditis.

Authors:  Neil J Scolding; Hiam Ali; Mary Sheppard; Andre R Simon
Journal:  Neurol Clin Pract       Date:  2021-02

Review 3.  Myocarditis: A Clinical Overview.

Authors:  A L P Caforio; G Malipiero; R Marcolongo; S Iliceto
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 3.955

4.  Recurrent giant cell myocarditis after heart transplant: a case report.

Authors:  Eitan S Frankel; Alexander G Hajduczok; Indranee N Rajapreyar; Yevgeniy Brailovsky
Journal:  Eur Heart J Case Rep       Date:  2022-09-05

5.  Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.

Authors:  Enrico Ammirati; Maria Frigerio; Leslie T Cooper; Paolo G Camici; Eric D Adler; Cristina Basso; David H Birnie; Michela Brambatti; Matthias G Friedrich; Karin Klingel; Jukka Lehtonen; Javid J Moslehi; Patrizia Pedrotti; Ornella E Rimoldi; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Circ Heart Fail       Date:  2020-11-12       Impact factor: 8.790
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.